(Q73304376)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Isabel Lastres-Becker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

María Gómez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Rosario De Miguel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

José A. Ramos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Javier Fernández-Ruiz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Neurotoxicity Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

7-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

601-608

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709298%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1080/10298420290030514

2 November 2019

exact match

0 references

cites work

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

1 reference

12 December 2020

Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia.

1 reference

12 December 2020

Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model

1 reference

12 December 2020

Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry

1 reference

12 December 2020

Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography

1 reference

12 December 2020

Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study.

1 reference

12 December 2020

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

12 December 2020

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

1 reference

12 December 2020

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease

1 reference

12 December 2020

Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing

1 reference

12 December 2020

Differential loss of striatal projection neurons in Huntington disease

1 reference

12 December 2020

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

1 reference

12 December 2020

Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.

1 reference

12 December 2020

Neuropathological classification of Huntington's disease

1 reference

12 December 2020

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

1 reference

12 December 2020

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

1 reference

12 December 2020

Effects of repeated administration of estradiol benzoate on tubero-infundibular GABAergic activity in male rats.

1 reference

12 December 2020

Measurement of GABA in rat brain microdialysates using o-phthaldialdehyde-sulphite derivatization and high-performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice

1 reference

12 December 2020

Recent advances in understanding the pathogenesis of Huntington's disease

1 reference

12 December 2020

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.

1 reference

12 December 2020

Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain

1 reference

12 December 2020

Neuron-specific enolase (NSE) and non-neuronal enolase (NNE) mRNAs are co-expressed in neurons of the rat cerebellum: in situ hybridization histochemistry.

1 reference

12 December 2020

Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

1 reference

12 December 2020

Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study

1 reference

12 December 2020

Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide.

1 reference

12 December 2020

Advances in Huntington's disease: implications for experimental therapeutics

1 reference

12 December 2020

Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.

1 reference

12 December 2020

3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration.

1 reference

12 December 2020

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease

1 reference

12 December 2020

Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease

1 reference

12 December 2020

Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

1 reference

12 December 2020

Brain cannabinoid systems as targets for the therapy of neurological disorders

1 reference

12 December 2020